Cost-effectiveness of coronary heart disease prevention;Kosten-Effektivität der KHK-Prävention.

Zeitschrift für Kardiologie

Volumn 91 Suppl 2, Issue , 2002, Pages 49-60

  Wendland, G ^a   Klever Deichert, G ^a   Lauterbach, K ^a  

^a Institut für Gesundheitsökonomie und klinische Epidemiologie Gleueler Str 176 178 50933 Köln ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT;

COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; COST BENEFIT ANALYSIS; DRUG COST; ECONOMICS; GERMANY; HUMAN; MORTALITY; QUALITY ADJUSTED LIFE YEAR; REVIEW; STATISTICS;

ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; CORONARY ARTERIOSCLEROSIS; COST-BENEFIT ANALYSIS; DRUG COSTS; GERMANY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; QUALITY-ADJUSTED LIFE YEARS;

EID: 0036364431     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (112)